fda warning glp-1 november 2025 issued 25 letters to telehealth companies for false and misleading claims about compounded products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of Pharmacovigilance Assessment of Compounded GLP-1
Description
Tirzepatide is a promising drug withdual-acting glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide 1 (GLP-1) receptor activation that has revolutionized the treatment of type 2 diabetesmellitus (T2DM) as an adjunct to ...
Weight Management Support A natural tool for those looking to maintain or reach a healthy weight, especially alongside diet and exercise
has officially crossed the $1 trillion market valuation, becoming the first healthcare company in history to reach the milestonea threshold previously dominated almost entirely by technology giants.
It helps you collect the right history, screen safety risks early, and route each patient to the correct next step before you invest provider time
This builds on what we already know: menopause fundamentally alters metabolism
Pfizer has struggled to develop a pill to join the makers of Ozempic and Mounjaro in the weight-loss gold rush.
